Orientador: Sisi Marcondes Paschoal / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-23T22:06:04Z (GMT). No. of bitstreams: 1 Lopes-Pires_MariaElisa_D.pdf: 1241899 bytes, checksum: a13986c42dd2369a280228a76009db4c (MD5) Previous issue date: 2013 / Resumo: A sepse e ainda causa de muitos óbitos em hospitais do mundo todo. A gravidade da sepse esta relacionada ao estado de ativação de plaquetas. Trabalho prévio do nosso grupo mostrou que o tratamento de ratos com lipopolissacarideo (LPS) leva a inibição da agregação plaquetaria e aumento da formação de espécies reativas de oxigênio (EROs) via NADPH oxidase. Entretanto, o efeito inibitório do LPS na agregação não e dependente da liberação de EROs. Portanto, o objetivo do presente trabalho foi investigar as vias de sinalização envolvidas na inibição da agregação e na ativação da NADPH oxidase em plaquetas de ratos tratados com LPS. Para tanto, ratos Wistar machos foram injetados com LPS (1 mg/kg, i.p.) e apos 6h ou 48h o sangue foi coletado. A agregação plaquetaria foi induzida por ADP (10 ?M) na ausência e na presença de diferentes inibidores enzimáticos. A formação de EROs em plaquetas foi determinada por citometria de fluxo utilizando a sonda fluorescente DCFH-DA e a concentração intraplaquetaria de GMPc por imunoensaio. Também foram realizados ensaios de western blotting para a analise da ativação das enzimas c-Src, AKT e NADPH oxidase, bem como para a detecção de proteínas contendo resíduos de nitrotirosina. A analise do western blotting mostrou que a fosforização da c-Src quinase no resíduo Tyr 416, que indica ativação da enzima, foi semelhante em plaquetas de ratos injetados com salina ou LPS em 6h ou 48h. Alem disso, a inibição de Src com PP2 (10 ?M) não modificou a agregação plaquetaria de ratos tratados com LPS. Nos verificamos que a inibição da agregação foi acompanhada por um aumento significativo dos níveis de GMPc, bem como da nitracao de proteínas, em plaquetas de ratos 6h ou 48h apos o tratamento com LPS. A incubação das plaquetas com o sequestrador de peroxinitrito -(-) epigalocatequina gallato (10 ?M) aumentou significativamente a agregação de ratos injetados com LPS em 48h, mas não alterou a agregação em 6h. Entretanto, a inibição da agregação plaquetaria em ratos tratados com LPS em 6h foi revertida pelo inibidor da enzima guanilil ciclase ODQ (25 ?M) ou pelo inibidor de PKG Rp-8-Br (25 ?M). De forma semelhante, o inibidor nao seletivo de PKC GF109203X (10 ?M) reverteu o efeito inibitório do LPS em 6h na agregação e reduziu os niveis de GMPc em plaquetas. Nos mostramos que a fosforização da AKT no resíduo Thr308 foi significativamente maior em plaquetas de ratos tratados com LPS quando comparado com ratos injetados com salina. A incubacao das plaquetas de ratos tratados com LPS com o inibidor de PI3K wortmannin (100 nM) nao modificou a agregação. Entretanto, o inibidor da AKT PPI-1 (20 ?M) aumentou a agregação para níveis semelhantes aos observados nos ratos injetados com salina. A agregação plaquetaria de ratos 48h apos o tratamento com LPS não foi afetada por nenhum dos inibidores enzimáticos utilizados neste trabalho. O aumento da geração de EROs em plaquetas de ratos tratados com LPS em 6h ou 48h foi acompanhado pelo aumento significativo da fosforização do resíduo Ser345 na subunidade p47-phox da NADPH oxidase. A incubação de plaquetas de ratos tratados com LPS com GF109203X inibiu a fosforização da p47-phox bem como reduziu a geração de EROS. A produção aumentada de EROs em plaquetas de ratos tratados com LPS em 6h também foi reduzida em 42% por PP2. A inibição de PI3K ou AKT não modificou a produção de EROS em plaquetas de ratos tratados com LPS. A incubação de plaquetas com ODQ ou com Rp-8-Br (5?M) reduziu significativamente a produção de EROS somente em plaquetas de ratos 48h apos o tratamento com LPS. Portanto, no presente trabalho podemos concluir que a inibição da agregação plaquetaria observada 6h apos a injeção de LPS e mediada pela via NO/GMPc/PKG e também e modulada pela PKC e AKT, enquanto que, o efeito inibitório do LPS em 48h e essencialmente dependente da formação de peroxinitrito. A produção aumentada de EROs em plaquetas de ratos tratados com LPS envolve a fosforização da subunidade p47-phox da NADPH oxidase pela PKC. Alem da PKC, são importantes no aumento da liberação de EROs em plaquetas a Src em 6h e a via GMPc/PKG em 48h apos a injeção de LPS / Abstract: Sepsis is still a cause of high mortality in hospitals all over the world and its severity is directly related to platelet activity. A previous work of our group showed that the treatment of rats with lipopolysaccharide (LPS) inhibited platelet aggregation and also increased reactive oxygen species (ROS) production which was mediated especially by NADPH oxidase. However, the inhibitory effect of LPS on platelet aggregation is independent of ROS formation. Therefore, in the present work we investigated the signaling pathways involved in the aggregation inhibition as well as in the increased ROS formation in platelets of LPS-treated rats. Male Wistar rats were injected with LPS (1 mg/kg, i.p.) and blood was collected after 6h or 48h. Platelet aggregation was induced by ADP (10 ?M) in the absence or in the presence of different enzymatic inhibitors. ROS formation in platelets was determined through flow cytometry using 2',7'-dichlorofluorescein diacetate (DCFHDA) and cGMP intraplatelet levels by enzyme immunoassay kit. Western blotting assays were carried out to analyze AKT and NADPH oxidase activation and the presence of nitrated proteins in platelets. In the present work, we observed that the inhibition of aggregation was accompanied by a significant increase of cGMP levels as well as protein nitration in platelets of LPS-treated rats. Incubation of platelets with the peroxynitrite scavenger -(-) epigallocatechingallate (10 ?M) significantly increased aggregation of LPS-treated rats at 48h, but did not modify it at 6h. However, the inhibitory effect of LPS at 6h on platelet aggregation was reversed by the guanylyl cyclase (sGC) inhibitor ODQ (25 ?M) or by the PKG inhibitor Rp-8-Br (25 ?M). Likewise, the PKC inhibitor GF109203X (10 ?M) reversed the inhibition of aggregation and the increased cGMP levels in platelets of LPS-treated rats at 6h. We demonstrated that AKT phosphorylation at Thr308 was significantly higher in platelets of LPS-injected rats than in the saline group. The AKT inhibitor PPI-1 (20 ?M) increased platelet aggregation of rats 6h after LPS-injection to the levels comparable to the saline group, despite of the PI3K inhibitor wortmannin (100 nM) has had no effect. Platelet aggregation of rats 48h after LPS injection was not affected by any enzymatic inhibitors used in this work. Increased ROS formation in platelets of LPS injected rats at 6h or 48h was followed by a marked increase of the NADPH oxidase subunit p47-phox phosphorylation at Ser345. Incubation of platelets of LPS-injected rats with GF109203X inhibited the p47-phox phosphorylation as well as ROS generation. The increased ROS production in platelets of rats 6h after LPS-injection was reduced 42% by PP2. Inhibition of both PI3K and AKT did not change ROS production in platelets of LPS-injected rats. Incubation of either ODQ or Rp-8-Br (5 ?M) reduced significantly the ROS production just in platelets of rats 48h after LPS-injection. Therefore, our results show that the inhibition of ADP-induced platelet aggregation of rats 6h after LPS injection is mediated by NO/cGMP/PKG-dependent mechanisms, and PKC and AKT probably act upstream upregulating this pathway. On the other hand, the inhibitory effect of LPS at 48h on platelet aggregation is essentially dependent on ONOO- production. In addition, our results show that the augmented ROS production in platelets of LPS-treated rats is mediated by PKCdependent phosphorylation of p47-phox. Besides PKC, the increased ROS formation in platelets is also modulated by Src at 6h after LPS injection, while NO/cGMP/PKG pathway takes part of this effect at 48h / Doutorado / Farmacologia / Doutora em Farmacologia

Le polynucléaire neutrophile (PMN), cellule clé de l’immunité innée, est la première cellule à être recrutée sur le site inflammatoire. Après avoir détruit l’agent pathogène, il entre en apoptose puis est éliminé par les macrophages pour éviter le déversement de son contenu lytique, dangereux pour l’environnement. La régulation de la balance survie/apoptose du neutrophile est donc une étape cruciale de la résolution de l’inflammation. Notre laboratoire a mis en évidence la présence du Proliferating Cell Nuclear Antigen (PCNA) dans le neutrophile mature. PCNA est exprimé dans le noyau des cellules proliférantes, où il est impliqué dans la réplication/réparation de l’ADN et dans le contrôle du cycle cellulaire. PCNA est une protéine trimérique conservée au cours de l’évolution dépourvue d’activité enzymatique. En effet, PCNA constitue une “plateforme” qui interagit avec différents partenaires protéiques et orchestre leurs fonctions. De plus, pour assurer sa fonction, PCNA doit être obligatoirement sous forme trimérique. Dans le neutrophile mature, il a été démontré que PCNA avait une localisation exclusivement cytosolique et qu’il contrôlait spécifiquement la survie du neutrophile. La translocation de PCNA du noyau au cytosol a lieu pendant la différenciation granulocytaire. Elle est dépendante d'une séquence d'export nucléaire (NES) accessible et fonctionnelle que lorsque PCNA est monomérique. Le but de ma thèse a été d’étudier la plateforme de PCNA dans le cytosol du neutrophile afin d'identifier les protéines associées à PCNA afin de comprendre sa fonction dans les neutrophiles. Nous avons montré la présence de la forme monomérique et de la forme trimérique de PCNA dans le cytosol du neutrophile mature. Nous avons démontré une activité anti-apoptotique de la forme monomérique dans des cellules PLB985 différenciées en neutrophiles. De plus, nous avons identifié des peptides exposés sur la surface monomérique de PCNA qui sont utilisé comme des compétiteurs pour déplacer les interactions entre PCNA et ses partenaires dans le cytosol des neutrophiles. Ces peptides modulent la survie des neutrophiles. Grâce à des analyses de Spectrométrie de Masse, nous avons identifié des nouveaux partenaires de PCNA dans le cytosol du neutrophile impliqués dans plusieurs voies métaboliques. Cela suggère que PCNA régule la survie du neutrophile en interagissant avec différents protéines cytosoliques. Parmi les partenaires identifiés, nous avons trouvé les sous-unités cytosoliques de la NADPH oxydase, enzyme responsable de la production de formes réactives de l’oxygène, à la base de l’activité microbicide du neutrophile. Nous avons montré en particulier l’interaction entre p47phox et PCNA. Nous avons enfin étudié l’implication fonctionnelle de l’interaction de PCNA avec la NADPH oxydase dans des cellules PLB985 et également dans des neutrophiles humains. L’ensemble des résultats suggère que PCNA cytoplasmique maintient le neutrophile dans un état de repos, et aide l’assemblage de la NADPH oxydase lors de son activation. Le réseau protéique associé à PCNA régule l’activité et la survie du neutrophile en modulant différentes voies de signalisation. / Polymorphonuclear neutrophils (PMN), key cells of innate immunity are the first cell recruited to the inflammatory site. After destroying the pathogen, neutrophils undergo apoptosis and are cleared by macrophages to prevent the spillage of their lytic content that is dangerous for the environment. The regulation of the survival/apoptosis balance of neutrophil is a crucial step in the inflammation resolution. Our laboratory has shown the presence of Proliferating Cell Nuclear Antigen (PCNA) in mature neutrophils. PCNA is expressed in the nucleus of proliferating cells, where it is involved in DNA replication/repair and in cell cycle control. PCNA is a trimeric protein conserved during evolution and deprived of enzymatic activity. Indeed, PCNA is a “platform” that interacts with different partner proteins and orchestrates their functions. Furthermore, PCNA must be in trimeric form to play its role. In mature neutrophils, PCNA has an exclusively cytosolic localization where it specifically controls their survival. The PCNA translocation from nucleus to the cytosol happened during the granulocytic differentiation. This nuclear-to-cytosol relocalisation is dependent on a nuclear export sequence (NES), which is accessible and functional when PCNA is monomeric. The aim of my thesis was to study the PCNA platform in the neutrophil cytosol to identify the proteins associated with PCNA in order to understand its function in neutrophils. We have shown the expression of monomeric and trimeric forms of PCNA in the cytosol of mature neutrophils. We have demonstrated the anti-apoptotic activity of the monomeric form in PLB985 cells differentiated in neutrophils. Moreover, we have identified the surface-exposed peptides from the monomeric PCNA which are used as competitors of interactions between PCNA and its partner in the cytosol of neutrophils. These peptides modulate neutrophils survival. Thanks to the analysis of Mass Spectrometry, we have identified new partners of PCNA in the neutrophil cytosol involved in several metabolic pathways. This suggests that PCNA regulates neutrophil survival by interacting with different cytosolic proteins. Among the identified partners, we have found the cytosolic subunits of the NADPH oxidase, the enzyme responsible of the reactive oxygen species production, at the base of the neutrophil microbicidal activity. We have shown especially the interaction between p47phox and PCNA. Finally, we have investigated the functional implication of the interaction of PCNA with the NADPH oxidase in PLB985 cells and also in human neutrophils. Taken altogether, results suggest that the cytosolic PCNA maintains the resting state of neutrophils, and it helps the assembly of the NADPH oxidase when activated. The protein network associated with PCNA regulates the activity and the survival of neutrophil by modulating several pathways.

La NADPH oxydase de phagocyte est un complexe enzymatique impliqué dans la défense immunitaire contre les pathogènes. Elle est constituée du flavocytochrome b558 membranaire (Cyt b558), composé de deux sous-unités (gp91phox et p22phox) et de quatre sous-unités cytosolubles, p47phox, p67phox, p40phox, et Rac. Sa fonction est de produire au niveau de la paroi des pathogènes des ions superoxyde (O2•−) qui sont transformés en d'autres espèces réactives de l'oxygène (ROS) qui attaquent les lipides, les protéines et l’ADN environnants. Après activation du phagocyte, les sous-unités cytosoliques subissent des modifications post-traductionnelles et migrent vers la membrane pour constituer le complexe NADPH oxydase activé. Le rôle délétère des ROS dans les maladies est connu depuis longtemps. Le but de ma thèse a été d’étudier l’influence de molécules exogènes qui induisent une augmentation du stress oxydatif, sur l’activité de la NADPH oxydase.Dans ce travail, nous avons étudié le fonctionnement de la NADPH oxydase dans un système in vitro dans lequel l’enzyme était activée par la présence d'acide arachidonique (AA). J’ai étudié l'influence de deux types de molécules: une classe de lipides et des nanoparticules (NPs). Pour simplifier le système, nous avons remplacé l’ensemble des sous-unités cytosoliques par une protéine unique appelé trimère qui correspond à une fusion des trois protéines cytosoliques p47phox, p67phox et Rac. Nous avons montré que le trimère est fonctionnellement comparable aux sous-unités cytosoliques séparées. La vitesse de production de O2•−, sa dépendances en fonction de la concentration en AA et de la température, et sa sensibilité aux radicaux libres étaient comparables lorsque le trimère ou les sous-unités séparées étaient utilisés.J’ai étudié les conséquences de la présence de cholestérol et de ses formes oxydées sur la production de O2•− par la NADPH oxydase. Nos résultats montrent clairement que le cholestérol et l’oxystérols ne sont pas des activateurs efficaces de la NADPH oxydase. L’addition d’une quantité physiologique de cholestérol déclenche une faible production d’ions superoxyde. L’addition de cholestérol à des concentrations du même ordre de grandeur pendant le processus d'assemblage (en présence de AA), a un rôle inhibiteur sur la production d’O2•−. Le cholestérol ajouté agit sur les composantes, cytosoliques et membranaires, conduisant à un assemblage imparfait. En conclusion, le cholestérol déjà présent dans la membrane des neutrophiles est optimale pour le fonctionnement de la NADPH oxydase.Il était intéressant de vérifier l'influence des nanoparticules de dioxyde de titane (TiO2) et de platine (Pt) sur le comportement de la NADPH oxydase sachant que l'internalisation cellulaire de ces NPs a pour effet d’activer les neutrophiles et les macrophages et contribue à une sur-production de ROS. En l’absence d'activateur mais en présence de NPs de TiO2 ou Pt, aucune production de O2•− n’était détectée indiquant que les NPs de TiO2 et Pt sont incapables d'activer le complexe par eux-mêmes aussi bien dans le système acellulaire que dans les neutrophiles. Cependant, une fois la NADPH oxydase activée (par AA), la vitesse de production des O2•− est augmentée jusqu’à 40% de sa valeur en l’absence de NPs de TiO2, cet effet étant fonction de leur concentration. Par contre, les NPs de Pt n’ont aucun effet sur l’activité de la NADPH oxydase aussi bien in vitro que dans les neutrophiles. En conclusion, l'hyperactivation de la NADPH oxydase et l'augmentation subséquente de la production de ROS induites par les NPs de TiO2 pourraient participer au développement du stress oxydatif tandis que l'absence d'effet Pt-NPs suggère qu'ils ne provoquent pas de sur-inflammation. / NADPH oxidase from phagocytes is a multi-subunit enzyme complex involved in the innate defense of organisms against pathogens. It is composed of the membrane-bound flavocytochrome b558 (Cyt b558), comprising two subunits (gp91phox, and p22phox) and four cytosolic components, p47phox, p67phox, p40phox, and Rac. Its function is to produce in the vicinity of the pathogen, superoxide ions that are transformed subsequently into other reactive oxygen species (ROS) and will damage lipids, proteins and DNA. Upon phagocyte activation, the cytosolic subunits undergo posttranslational modifications and migrate to the membrane bound Cyt b558 to constitute the activated NADPH oxidase complex. The damaging role of ROS in cardiovascular diseases has been known for some decades. The aim of my thesis was to study the influence on NADPH oxidase activity, of molecules coming from food and industrial products and known to be involved in increase of oxidative stress.In this work, we studied the NADPH oxidase functioning in an in vitro system in which the components of the enzyme are mixed and activated by the introduction of an amphiphile the arachidonic acid (AA). During my PhD, I have studied the influence of two types of oxidative stress participants: lipids and nanoparticles (NPs). For simplicity, we have replaced the cytosolic subunits by a single protein called trimera, which is a fused construction of three cytosolic proteins p47phox, p67phox and Rac. We have shown that trimera is functionally comparable with the separated cytosolic subunits. The rates of production of O2•−, the dependences of the activity in function of AA concentration and temperature, the presence of two states in the activation process and the sensitivity of NADPH oxidase to free radicals were comparable when either trimera or separated subunits were used.I investigated the consequences of the addition of cholesterol on NADPH oxidase, on the production of ROS. Our results clearly show that cholesterol and oxysterols are not efficient activators of NADPH oxidase. Concentrations of cholesterol similar to what found in neutrophiles trigger a low superoxide production. Addition of cholesterol during the assembly process (in presence of AA) at similar or higher concentrations, has an inhibitory effect on the production of O2•−. Added cholesterol acts on both cytosolic and membrane components, leading to imperfect assembly and decreasing the affinity of cytosolic subunits to the membrane ones. In conclusion, we showed that the cholesterol already present in the phagocyte membrane is optimal for the function NADPH oxidase.It was of interest to check the influence of titanium dioxide (TiO2) and platinum (Pt) NPs on NADPH oxidase especially that cellular internalization of NPs was shown to activate neutrophils and contribute to O2•− overproduction via NADPH oxidase. In the absence of activators and presence of TiO2 or Pt NPs, no production of O2•− could be detected in in vitro system as well as in neutrophils indicating that TiO2 and Pt NPs were unable to activate by themselves the complex. However once the NADPH oxidase was activated by AA, TiO2 NPs increased the rate of O2•− production by up to 40%, this effect being dependent on their concentration. Differently, Pt NPs had no effect both on in vitro system as well as on neutrophils. In conclusion, the hyper-activation of NADPH oxidase and the subsequent increase in ROS production by TiO2 NPs could participate to oxidative stress development while the absence of Pt-NPs effect suggest that they do not induce inflammation status via this complex.

Le symporteur Na+/I- (NIS) médie le captage de l'iode dans la glande thyroïde et cette propriété est exploitée depuis de nombreuses années en thérapeutique pour traiter les cancers différenciés de la thyroïde à l’iode radioactif 131 (Radiothérapie métabolique ou RAI). Cependant, 5 à 10% des patients deviennent réfractaires à la RAI, ce qui indique un mauvais pronostic. La réduction de l'expression NIS et son internalisation sont caractéristiques de ce processus. La mutation activatrice BRAFV600E est la plus fréquemment identifiée au sein des cancers différenciés de la thyroïde de type papillaires (CPT), qui est le type le plus répandu. Dans les thyrocytes de souris, BRAF muté induit la sécrétion de TGF qui active ensuite la voie Smad ce qui entraîne la répression du NIS. La NADPH oxydase 4 (NOX4), enzyme génératrice d’espèces réactives de l'oxygène (ROS), est un médiateur clé de la signalisation du TGFß dans de nombreux types cellulaires et sa surexpression a été détectée dans le cancer de la thyroïde. L'objectif de ce travail est d'évaluer si NOX4 est un médiateur de la répression NIS induite par BRAFV600E dans des lignées cellulaires thyroïdiennes. En utilisant une lignée cellulaire de thyroïde normal de rat (PC-BRAF), nous avons démontré que le TGF-β ou l'expression BRAFV600E promeut la diminution de l'ARNm NIS ainsi que celle du captage de l'iodure en revanche ils augmentent l’expression de l'ARNm NOX4. Le silençage de Nox4 par siRNA ou un traitement des cellules par SIS3, un inhibiteur de pSmad3, inhibe la répression du NIS médiée par BRAFV600E, indiquant l'implication de la voie Smad3 et de Nox4 dans cette répression. Dans la lignée tumorale BCPAP derivée d’un CPT humain et porteuse de la mutation BRAFV600E, nous avons également observé une augmentation de l'expression de l'ARNm NIS lorsque BRAFV600E ou NOX4 sont inhibés. Dans les cellules BCPAP, un traitement par H2O2 augmente l'expression de la protéine ADN méthyltransférase 1 (DNMT1) dans la fraction cellulaire enrichie en protéines liées à la chromatine. Un traitement par des antioxydants ou le silençage de NOX4 réduise ce recrutement. Le TGF augmente le niveaux de protéines DNMT1 dans la fraction cellulaire enrichie en chromatine, lequel qui est renversé par un traitement par un inhibiteur de NADPH oxydase : le Diphenyleneiodonium (DPI). La méthylation de l'ADN induite par le TGF et l'hypoacétylation de l'histone H3K9/K14, qui sont des marques de répression de la transcription, sont détectées au niveau du promoteur NIS. L’ensemble de ces données suggère que Nox4 est un acteur clé de la signalisation TGF-BRAFV600 et joue un rôle répressif sur l'expression du NIS, probablement par des mécanismes épigénétiques. Cette étude apporte des données fonctionnelles pour le développement de nouveaux outils thérapeutiques. / The co-transporter Na+/ I- (NIS) mediates iodide uptake in thyroid gland which is a key step in hormonal biosynthesis. Iodide accumulation by thyrocytes is the basis of radioiodine therapy (RAI) which is the standard post-surgery therapeutic approach to efficiently eliminate remaining cancer lesions and metastasis of differentiated thyroid cancer (DTC). However, 5-10% of DTC patients become RAI-refractory which is indicative of poor prognosis. Reduced NIS expression and NIS internalization are in this process. BRAFV600E mutation is the most common genetic event in papillary thyroid cancers (PTCs), the most prevalent type of DTC. In rat thyrocytes, BRAFV600E induces secretion of TGFβ that activates Smad pathway resulting in NIS downregulation and overexpression of TGFβ is associated with NIS repression in patients. NADPH oxidase NOX4, a professional reactive oxygen species (ROS) generating enzyme, is a key mediator of TGFβ signaling in many cell types and has been previously demonstrated to be overexpressed thyroid cancers. To better understand the molecular mechanisms involved in PTC loss of iodine avidity, the aim of this work is to evaluate whether NOX4 is a key player of BRAFV600E-mediated NIS repression in thyroid cell lines. Using a normal rat thyroid cell line (PC-BRAF) we demonstrated that TGF-β administration or expression of BRAFV600E resulted in reduced NIS mRNA, reduced iodine uptake and increased NOX4 mRNA expression. NOX4 silencing or treatment with SIS3 an inhibitor of Smad pathway partially inhibited NIS repression indicating the implication of both Smad pathway and NOX4. To confirm this results we used a human thyroid cancer cell lines that harbors BRAFV600E mutation (BCPAP and 8505c) and observed an increase in NIS expression followed by BRAFV600E or NOX4 downregulation. Exogenous H2O2 induced DNA methyl-transferase 1 (DNMT1) enrichment in tight-chromatin protein fraction which was decreased by antioxidants or NOX4 silencing in BCPAP cells. TGF increased DNMT1 protein levels in chromatin-enriched cell fraction which was reversed by NADPH oxidase inhibitor, Diphenyleneiodonium (DPI). TGF-mediated DNA methylation and histone H3K9/K14 hypoacetylation were detected in NIS promoter, which is a repressive transcriptional mark. The data obtained suggest that NOX4 is a mediator of BRAFV600-TGF signaling and has a repressive role over NIS expression probably through epigenetic mechanisms. These results should lead to a better understanding of NIS expression regulation in thyroid cancer, bringing functional data for the development of new therapeutic tools.

Several epidemiological studies found that hypertensive patients have an increased risk to develop kidney cancer. Hyperaldosteronism frequently results in arterial hypertension and contributes to the development and progression of kidney injury, with reactive oxygen species (ROS) playing an important role. ROS are thought to be associated with many pathological conditions such as cancer and other disorders, like cardiovascular complications , which often go along with hypertension. The aim of the present work was to investigate whether the effects of elevated aldosterone concentrations might be involved in the increased cancer incidence of hypertensive individuals. First, the potential capacity of aldosterone to induce oxidative stress and DNA damage was investigated in vitro and in vivo. In LLC-PK1 porcine kidney cells and MDCK canine kidney cells the significant formation of ROS, and especially of superoxide (O2˙ˉ) was assessed. With two genotoxicity tests, the comet assay and the micronucleus frequency test, the DNA damaging potential of aldosterone was quantified. In both genotoxicity tests a dose-dependent increase in aldosterone-induced structural DNA damage was observed. Oxidative stress and DNA damage were prevented by antioxidants, suggesting ROS as a major cause of DNA damage. Furthermore, the oxidatively modified DNA lesion 8-oxo-7,8-dihydro-2´-deoxyguanosine (8-oxodG), was found to be significantly elevated. In kidneys of rats with desoxycorticosterone acetate (DOCA)/salt-induced hypertension, which is a model of severe mineralocorticoid-dependent hypertension, elevated levels of ROS and superoxide were found, compared to kidneys of sham rats. Also DNA strand breaks, measured with the comet assay and double strand breaks, visualized with antibodies against the double strand break-marker gamma-H2AX were significantly elevated in kidneys of DOCA/salt-treated rats. In addition, significantly increased amounts of 8-oxodG were detected. Proliferation of kidney cells was found to be increased, which theoretically enables the DNA damage to manifest itself as mutations, since the cells divide. Second, the effects of aldosterone on the activation of transcription factors and signaling pathways were investigated. A significant activation of the potentially protective transcription factor Nrf2 was observed in LLC-PK1 cells. This activation was triggered by an increase of ROS or reactive nitrogen species (RNS). In response to oxidative stress, glutathione synthesis and detoxifying enzymes, such as the subunits of the glutathione-cysteine-ligase or heme oxygenase 1 were rapidly induced after 4 h. Nevertheless, after 24 h a decrease of glutathione levels was observed. Since ROS levels were still high after 24 h, but Nrf2 activation decreased, this adaptive survival response seems to be transient and quickly saturated and overwhelmed by ROS/RNS. Furthermore, Nrf2 activation was not sufficient to protect cells against oxidative DNA damage, because the amounts of double strand breaks and 8-oxodG lesions steadily rose up to 48 h of aldosterone treatment. The second transcription factor that was time- and dose-dependently activated by aldosterone in LLC-PK1 and MDCK cells was NF-kappaB. Furthermore, a significant cytosolic and nuclear activation of ERK was detected. Aldosterone induced the phosphorylation of the transcription factors CREB, STAT1 and STAT3 through ERK. Third, the underlying mechanisms of oxidant production, DNA damage and activation of transcription factors and signaling pathways were studied. Aldosterone exclusively acted via the MR, which was proven by the MR antagonists eplerenone, spironolactone and BR-4628, whereas the glucocorticoid receptor (GR) antagonist mifepristone did not show any effect. Furthermore, aldosterone needed cytosolic calcium to exert its negative effects. Calcium from intracellular stores and the influx of calcium across the plasma membrane was involved in aldosterone signaling. The calcium signal activated on the one hand, the prooxidant enzyme complex NAD(P)H oxidase through PKC, which subsequently caused the generation of O2˙ˉ. On the other hand, nitric oxide synthase (NOS) was activated, which in turn produced NO. NO and O2˙ˉ can react to the highly reactive species ONOO- that can damage the DNA more severely than the less reactive O2˙ˉ. In the short term, the activation of transcription factors and signaling pathways could be a protective response against aldosterone-induced oxidative stress and DNA damage. However, a long-term NF-B and ERK/CREB/STAT activation by persistently high aldosterone levels could unfold the prosurvival activity of NF-kappaB and ERK/CREB/STAT in aldosterone-exposed cells. DNA damage caused by increased ROS might become persistent and could be inherited to daughter cells, probably initiating carcinogenesis. If these events also occur in patients with hyperaldosteronism, these results suggest that aldosterone could be involved in the increased cancer incidence of hypertensive individuals. / Mehrere epidemiologische Studien haben ein erhöhtes Nierenkrebsrisko bei Patienten mit Bluthochdruck aufgedeckt. Hyperaldosteronismus führt oft zu arteriellem Bluthochdruck und trägt zur Entwicklung und zum Fortschreiten von Nierenschäden bei, wobei reaktive Sauerstoffspezies (ROS) eine wichtige Rolle spielen. Immer häufiger werden ROS mit Krankheitsbildern wie Krebs und kardiovaskulären Erkrankungen, die mit Bluthochdruck einhergehen, in Verbindung gebracht. Das Ziel dieser Arbeit war es, zu untersuchen, ob erhöhte Aldosteronkonzentrationen an dem gesteigerten Krebsrisiko von hypertensiven Patienten beteiligt sein könnten. Zunächst wurde die potentielle Kapazität von Aldosteron, oxidativen Stress und DNA-Schaden in vitro und in vivo induzieren zu können, untersucht. In der Schweine-Nierenzelllinie LLC-PK1 und der Hunde-Nierenzelllinie MDCK wurde die Entstehung von ROS und speziell die Bildung von Superoxid (O2˙ˉ) nachgewiesen. Das gentoxische Potential von Aldosteron wurde mit zwei Genotoxizitätstests, dem Comet Assay und dem Mikrokernfrequenztest bestimmt. In beiden Genotoxizitätstests konnte ein dosis-abhängiger Anstieg des strukturellen DNA-Schadens beobachtet werden. Antioxidantien konnten den oxidativen Stress und die DNA-Schäden verringern, was annehmen lässt, dass ROS die Hauptursache für die Entstehung der DNA-Schäden sind. Darüberhinaus wurden signifikant erhöhte Mengen der oxidativ modifizierten DNA Läsion 8-Oxo-7,8-dihydro-2´-deoxyguanosin (8-oxodG) gefunden. In Nieren von Ratten mit Desoxycorticosteron-Acetat (DOCA) und Salz-induziertem Bluthochdruck, ein Modell für massiven Mineralocorticoid-induzierten Bluthochdruck, wurde ebenfalls eine erhöhte Bildung von ROS und O2˙ˉ in Nieren von DOCA/Salz-Ratten im Vergleich zu Sham-Ratten beobachtet. Auch im Comet Assay erfasste DNA-Strangbrüche und Doppelstrangbrüche, die mit Hilfe von Antikörpern gegen den Doppelstrangbruchmarker gamma-H2AX sichtbar gemacht wurden, waren in den Nieren der DOCA/Salz-behandelten Ratten signifikant erhöht. Weiterhin wurden erhöhte 8-oxodG-Spiegel in DOCA/Salz-Ratten beobachtet. Auch eine erhöhte Proliferationsrate in DOCA/Salz-behandelten Ratten konnte festgestellt werden, was theoretisch dazu führen könnte, dass sich die DNA-Schäden als Mutationen manifestieren, da sich die Zellen teilen. Im zweiten Teil der Arbeit wurde der Einfluss von Aldosteron auf die Aktivierung von Transkriptionsfaktoren und Signalwegen untersucht. Zunächst konnte die Aktivierung des potentiell schützenden Transkriptionsfaktors Nrf2 in LLC-PK1 Zellen mittels electrophoretic mobility shift assay (EMSA) beobachtet werden. Diese Aktivierung wurde durch den Anstieg an ROS und reaktiven Stickstoffspezies (RNS) ausgelöst. Als Antwort auf den oxidativen Stress, wurde die Glutathion-Synthese und detoxifizierende Enzyme, wie die Untereinheiten der Glutathion-Cystein-Ligase oder Hämoxygenase 1, nach 4 Stunden rasch hochreguliert. Nichtsdestotrotz konnte nach 24 Stunden eine Abnahme des Glutathionspiegels festgestellt werden. Da die Konzentration an ROS nach 24 Stunden immer noch signifikant erhöht war, die Aktivierung von Nrf2 allerdings stark zurückgegangen ist, scheint diese adaptive Überlebensstrategie nur kurzfristig, und somit schnell durch ROS/RNS gesättigt zu sein. Weiterhin war die Aktivierung von Nrf2 nicht ausreichend, um die Zellen vor dem durch Aldosteron-induzierten DNA-Schaden zu schützen, da Doppelstrangbrüche, sowie 8-oxodG-Läsionen bei bis zu 48-stündiger Inkubation mit Aldosteron stetig anstiegen. Der zweite Transkriptionsfaktor, der zeit- und dosisabhängig durch Aldosteron aktiviert wurde, war NF-kappaB. Ausserdem wurde die cytosolische und nukleäre Aktivierung von ERK nachgewiesen. Aldosteron induzierte weiterhin die Phosphorylierung der Transkriptionsfaktoren CREB, STAT1 und STAT3 durch ERK. Im dritten Teil dieser Arbeit wurden die zugrundeliegenden Mechanismen der Entstehung von ROS/RNS, des DNA-Schadens und der Aktivierung von Transkriptionsfaktoren untersucht. Aldosteron wirkte ausschließlich über den MR, bewiesen durch Einsatz der MR-Antagonisten Eplerenon, Spironolakton und BR-4628. Der Glucocorticoid-Rezeptor-Antagonist Mifepriston zeigte dagegen keinen Effekt. Weiterhin benötigte Aldosteron cytosolisches Calcium, um seine negativen Effekte auszuüben. Es waren intrazelluäres Calcium, sowie ein Calciuminflux über die Plasmamembran am Aldosteronsignal beteiligt. Einerseits wurde der prooxidative Enzymkomplex NAD(P)H-Oxidase von Calcium durch die Proteinkinase C (PKC) aktiviert, was wiederum zur Bildung von O2˙ˉ führte. Andererseits kam es durch erhöhtes cytosolisches Calcium zur Aktivierung der NO-Synthase (NOS), welche daraufhin Stickoxid (NO) produzierte. NO und O2˙ˉ können zu dem hochreaktiven Peroxynitrit (ONOO-) reagieren, welches die DNA mehr schädigen kann als das etwas weniger reaktive O2˙ˉ. Kurzfristig könnte die Aktivierung der Transkriptionsfaktoren und Signalwege eine schützende Wirkung gegen den durch Aldosteron-induzierten oxidativen Stress und DNA-Schaden in den Zellen haben. Allerdings kann eine länger anhaltende Aktivierung von NF-kappaB und ERK/CREB/STAT durch permanent hohe Aldosteronspiegel zur Induktion einer Überlebensstrategie durch NF-kappaB und ERK/CREB/STAT in Aldosteron-exponierten Zellen führen. Der DNA-Schaden, der durch erhöhte ROS-Spiegel entsteht, könnte persistent und somit an Tochterzellen weitervererbt werden, was eventuell zur Entstehung von Krebs beitragen könnte. Falls diese Effekte auch in Patienten mit Hyperaldosteronismus gefunden werden können, dann könnte Aldosteron an der erhöhten Krebsinzidenz bei Bluthochdruck beteiligt sein.

A espécie Garcinia brasiliensis, conhecida como "bacupari", é nativa da Amazônia e cultivada em todo o território brasileiro. Na medicina popular, suas folhas são utilizadas para tratar tumores, inflamações das vias urinárias e artrite, bem como para aliviar dores. Este trabalho foi conduzido para avaliar a atividade analgésica e antiinflamatória do extrato etanólico foliar (GbEE) e da 7-epiclusianona, uma benzofenona natural poliprenilada isolada de suas folhas, em modelos animais in vivo. A ação deste benzofenona também foi investigada em um ensaio antiinflamatório ex vivo, enfocando o “burst” respiratório de neutrófilos e as vias bioquímicas envolvidas. Foi constatada atividade atividade antiinflamatória tanto para GbEE v.o. ( 30, 100 3 300 mg /kg) como para 7-epiclusianona v.o.(5, 10 e 15mg/Kg) por reduzir o edema de pata induzido por carragenina e inibir o recrutamento de leucócitos na cavidade peritoneal. Além disso, através do modelo de indução de inflamação crônica foi observado uma redução estatisticamente significativa de formação do tecido granulomatoso. Por outro lado, efeito antinociceptivo periférico foi atribuído ao GbEE sugerindo ser mais eficaz contra dores inflamatórias, enquanto que para a benzofenona foi constatada tanto atividade antinociceptiva periférica como central, através de diferentes mecanismos. O composto 7-epiclusianona (10 a 100µg) também foi capaz de reduzir e até mesmo suprimir a liberação de ânion superóxido por fagócitos inflamatórios através de um mecanismo controlado pela fosforilação da proteína tirosina e pela estimulação direta da proteína quinase C, sugerindo novas abordagens terapêuticas para o tratamento de processos inflamatórios e desenvolvimento de novos fármacos. Os resultados mostraram atividades antiinflamatória e analgésica das folhas de G. brasiliensis e da benzofenona isolada, confirmando o uso tradicional dessa espécie para tratamento de dores e inflamações. / The species Garcinia brasiliensis, known as “bacupari”, is native to the Amazon and cultivated throughout Brazil. Their leaves are used in folk medicine to treat tumors, inflammation of the urinary tract and arthritis as well as to relief pain. This study was conducted to evaluate the anti-inflammatory and analgesic effects of the ethanolic extract of leaves (GbEE) and the 7-epiclusianone, a natural polyisoprenilated benzophenone isolated from G. brasiliensis, in several animal models. The action of the benzophenone was also investigated ex vivo throughout an anti-inflammatory assay, focusing neutrophil respiratory burst and the biochemical pathway. Antiinflammatory activity was found for both GbEE (30, 100 and 300 mg /kg) p.o. and for 7-epiclusianone (5, 10 and 15mg/kg) p.o. to reduce the paw edema induced by carrageenan and to inhibit leukocyte recruitment into the peritoneal cavity. In addition, through the induction model of chronic inflammation, was observed a statistically significant reduction of granulomatous tissue formation. Moreover, peripheral antinociceptive effect was attributed to GbEE suggesting that this extract could be more effective against inflammatory pain, whereas for benzophenone was verified both peripheral and central antinociceptive activity through different mechanisms.The compound 7-epiclusianone (10 to 100 μg) was also able to reduce and even suppress the release of superoxide anion by inflammatory phagocytes through a mechanism controlled by protein tyrosine phosphorylation and by direct stimulation of protein kinase C, suggesting new therapeutic approaches for the treatment of inflammatory processes and development of new drugs. So, it was demonstrated the anti-inflammatory and antinociceptive activities of the leaves of G. brasiliensis and the benzophenone isolated which supports previous claims of the traditional use of this species against inflammation and pain. / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES

No description available.

This thesis presents an effort to understand the C-H-C transfer in enzymatic reactions from the comparison of different variants of enzymes that have unrelated protein sequences and structures, but catalyze the same chemical transformation. I evaluated the kinetic isotope effects (KIEs) and their temperature dependences and interpreted the findings in accordance with Marcus-like models. The enzyme system studied is dihydrofolate reductase (DHFR), which catalyzes the reduction of 7,8-dihydrofolate (H2F) to 5,6,7,8-tetrahydrofolate (H4F) using reduced β-nicotinamide adenine dinucleotide 2' phosphate (NADPH) as a reducing agent. H-transfer reactions in typical enzymes from three genetically unrelated families, E. coli chromosomal DHFR (cDHFR, FolA), plasmid coded R67 DHFR (FolB), and pteridine reductase 1 (PTR1, FolM) were comparatively investigated. Chapter I provides a brief introduction to the thesis. Chapter II presents optimized procedures for a one-pot, enzymatic microscale synthesis of several NADPH isotopologues used in KIE experiments. Chapter III focuses on the application of novel competitive primary H/D KIE determinations. Chapter IV compares the H-transfer reactions between primitive R67 DHFR and the chromosomal DHFR, and Chapter V describes the investigation of H-transfer reactions at high and low ionic strengths with theoretical and experimental approaches in order to understand the unusual enhancement in H-transfer rate of R67 DHFR with increasing ionic strength. Chapter VI discusses an improved PTR1 purification procedure and comparisons of steady state kinetic parameters using PTR1 and cDHFR with H2F and dihydrobiopterin (H2B) substrates. Thus, the investigation of the H-transfer reaction catalyzed by cDHFR with an unnatural substrate, H2B is described. Finally, a summary is provided and future directions are discussed in Chapter VII.

Neutrophils (PMN) and group IIA phospholipase A2 (gIIA PLA2) are components of the innate immune system mobilized to sites of invasion by microorganisms such as Staphylococcus aureus. Although accumulating coincidentally in vivo, the in vitro anti-staphylococcal activities of PMN and gIIA PLA2 have thus far been separately studied. The goal of this thesis was to study the collaborative activity of PMN and gIIA PLA2 against S. aureus. We have identified and characterized the collaboration of PMN and gIIA PLA2 against S. aureus ingested by PMN. PMN induced conversion of bacterial phosphatidylglycerol into cardiolipin, but were unable to degrade S. aureus phospholipids without gIIA PLA2. PMN reduced by 10-fold the concentration of gIIA PLA2 needed to digest bacterial phospholipids alone. In addition to increased phospholipid degradation, collaboration of PMN and gIIA PLA2 caused greater bacterial killing and greater loss of bacterial green fluorescent protein fluorescence. The collaboration of PMN and gIIA PLA2 against S. aureus is dependent on catalytic activity and is specific to gIIA PLA2 as related secretory PLA2, groups IB, V, and X, show little or no phospholipid degradation of S. aureus either alone or in the presence of PMN. Synergy of PMN and gIIA PLA2 requires a functional NADPH oxidase and phagocytosis. Although addition of gIIA PLA2 after phagocytosis causes some bacterial phospholipid degradation, the greatest effect is observed when gIIA PLA2 is added before phagocytosis. An extracellular source of H2O2 can partially restore antibacterial activities to NADPH oxidase deficient PMN including the ability to collaborate with gIIA PLA2, supporting a role for reactive oxygen species in NADPH oxidase dependent antimicrobial functions of PMN. In contrast, iberiotoxin, an inhibitor of BK potassium channels had no effect of PMN antibacterial activities. Although H2O2 partially restored antibacterial activity to NADPH oxidase deficient PMN, extracellular H2O2 was not sufficient to increase S. aureus to gIIA PLA2 activity. In summary, PMN and gIIA PLA2 collaborate against S. aureus. These findings revealed collaboration between cellular oxygen-dependent and extracellular oxygen-independent host defense systems that may be important in the ultimate resolution of S. aureus infections.

Neutrophils, essential innate immune cells, recognize danger signals through receptors on their surface. Upon receptor ligation, neutrophils may undergo priming, a process involving limited reactive oxygen species (ROS) generation and partial degranulation. Priming facilitates neutrophil migration and prepares the cell for an enhanced response to a secondary stimulus, including a spike in ROS generation by NADPH oxidase 2 (NOX2). It is well established that NOX2-derived oxidants are involved in pathogen killing and that off-target effects can cause host tissue damage; however, several lines of recent evidence also support an anti-inflammatory function for NOX2 oxidants. First, patients with chronic granulomatous disease exhibit sterile inflammatory phenomena. Second, neutrophils lacking NOX2 function (genetically or pharmacologically) have an inflammatory phenotype under resting conditions. Finally, NOX2-deficient mice exhibit enhanced localized inflammation in several disease models. The goals of this thesis were to investigate an anti-inflammatory function for NOX2 during systemic inflammation and to further elucidate mechanisms of neutrophil priming, with particular focus on priming through Toll-like receptor 2 (TLR2). Using a murine model of sterile systemic inflammatory response syndrome (SIRS), we observed that NOX2-deficient mice had dramatically increased mortality compared to WT mice. While both genotypes developed SIRS, characterized by hypothermia, hypotension, and leukopenia, the WT mice recovered within 48 h whereas the NOX2-deficient mice did not. Moreover, NOX2 function limited the extent of pulmonary pathology as significant lung injury was noted in the NOX2-deficient mice compared to the WT mice. Plasma analysis revealed that several inflammatory cytokines were persistently elevated in the NOX2-deficient mice, likely contributing to the ongoing inflammatory response. One of the complications seen in human SIRS patients is the development of multiple organ dysfunction syndrome (MODS). Thus, we next investigated the role of NOX2 in the progression from SIRS to MODS. Cellular analysis revealed continued neutrophil recruitment to the peritoneum and lungs of the NOX2-deficient mice and altered activation states of both neutrophils and macrophages. Histology showed multiple organ pathology indicative of MODS in the NOX2-deficient mice, and several inflammatory cytokines were elevated in lungs of the NOX2-deficient mice. Overall, these data suggest that NOX2 function protects against the development of MODS and is required for normal resolution of systemic inflammation. As we utilized a TLR2/6 agonist (zymosan) to induce SIRS in our in vivo model, we wanted to investigate neutrophil priming through TLR2 in an in vitro model. Notably, we determined that a TLR2/6 agonist, FSL-1, primed neutrophils from all donors to a similar extent, evidenced by direct and primed ROS generation, MAPK signaling, limited degranulation, and cytokine secretion. Surprisingly, Pam3CSK4, a TLR2/1 agonist, primed neutrophils from a subset of donors to a much greater extent than neutrophils from other donors. We demonstrated that the different neutrophil priming responses were the consequence of a common TLR1 polymorphism. In sum, the data presented here significantly advance our understanding of the roles of NOX2 and TLR2 signaling in host inflammation and neutrophil priming. This research could advance the development of therapies that target pathogenic neutrophil subsets in inflammatory conditions without compromising innate immune function